SplitApr 23, 2026, 08:36 AM
Immunic Inc. to Effect 1-for-10 Reverse Stock Split
AI Summary
Immunic, Inc. announced a 1-for-10 reverse stock split of its common stock, effective April 22, 2026, following stockholder approval on April 14, 2026. The post-split shares are expected to commence trading on the Nasdaq Capital Market under the existing symbol "IMUX" on April 27, 2026. This action will reduce the number of outstanding shares from approximately 136 million to 13.6 million, aiming to increase the per-share price.
Key Highlights
- Stockholders approved 1-for-10 reverse stock split.
- Effective April 22, 2026; trading post-split on April 27, 2026.
- Outstanding shares reduced from approximately 136 million to 13.6 million.
- New CUSIP identifier: 4525EP200.